- ImCheck Therapeutics received €1M in non-dilutive funding from Bpi France after its first fundraising round pulled in €20M last May.
- Nicox has teamed up with pSivida to develop a sustained release drug to lower intraoculaire pressure in glaucoma patients
- Italian synbio company Double Helix Technologies has signed Agilent as a partner to develop a SureVector cloning system
- Synaffix took home another milestone of undisclosed size from ADC Therapeutics
Images via Kobby Dagan, Parkol / shutterstock.com